These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24111619)

  • 1. Underlying pathways for interferon risk to type II diabetes mellitus.
    Abdel-Hamid N; Jubori TA; Farhan A; Mahrous M; Gouri A; Awad E; Breuss J
    Curr Diabetes Rev; 2013 Nov; 9(6):472-7. PubMed ID: 24111619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus during interferon therapy].
    Tarabini-Castellani P; Apraiz L; Portu J; Agud JM
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?
    Vanni E; Bugianesi E; Saracco G
    Dig Liver Dis; 2016 Feb; 48(2):105-11. PubMed ID: 26614641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
    Vanni E; Abate ML; Gentilcore E; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M; Marchesini G; Gastaldelli A; Bugianesi E
    Hepatology; 2009 Sep; 50(3):697-706. PubMed ID: 19582803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.
    Harrison SA; Hamzeh FM; Han J; Pandya PK; Sheikh MY; Vierling JM
    Hepatology; 2012 Aug; 56(2):464-73. PubMed ID: 22334369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications.
    Hung CH; Lee CM; Lu SN
    Expert Rev Anti Infect Ther; 2011 May; 9(5):525-33. PubMed ID: 21609264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Popescu C; Popescu GA; Arama V
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Cozzolongo R; Betterle C; Fabris P; Paola Albergoni M; Lanzilotta E; Manghisi OG
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):689-92. PubMed ID: 16702861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pancreatic autoantibodies and human leukocyte antigen haplotypes with resolution of diabetes mellitus after therapy for hepatitis C virus infection in patients with HIV infection: case report and review of literature.
    Lo YC; Chang SY; Sheng WH; Hung CC; Chang SC
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):478-81. PubMed ID: 19369830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.
    Kose S; Gozaydin A; Akkoclu G; Ece G
    J Infect Dev Ctries; 2012 Apr; 6(4):364-8. PubMed ID: 22505448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M; Peters T; Rasenack J; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C.
    Yamazaki M; Sato A; Takeda T; Komatsu M
    Intern Med; 2010; 49(5):403-7. PubMed ID: 20190473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C.
    Chedin P; Cahen-Varsaux J; Boyer N
    Ann Intern Med; 1996 Sep; 125(6):521. PubMed ID: 8779481
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Tanaka J; Sugimoto K; Shiraki K; Beppu T; Yoneda K; Fuke H; Yamamoto N; Ito K; Takei Y
    Intern Med; 2008; 47(8):747-9. PubMed ID: 18421192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
    Tai TY; Lu JY; Chen CL; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS; Chuang LM; Jeng YM
    J Endocrinol; 2003 Sep; 178(3):457-65. PubMed ID: 12967337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin resistance in chronic hepatitits C].
    Parise ER; Oliveira AC
    Arq Gastroenterol; 2007; 44(2):178-84. PubMed ID: 17962866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.